Pancreatic cancer is considered a “cold tumor” and lacks CD8+ tumor infiltrating lymphocytes, and using immune checkpoint antibodies has thus far largely failed in this malignancy [8]; therefore, chemotherapy remains the mainstay treatment for advanced pancreatic cancer. Here, CD8A is linked to familial pancreatic carcinoma.